1. Home
  2. UVSP vs GERN Comparison

UVSP vs GERN Comparison

Compare UVSP & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UVSP
  • GERN
  • Stock Information
  • Founded
  • UVSP 1876
  • GERN 1990
  • Country
  • UVSP United States
  • GERN United States
  • Employees
  • UVSP N/A
  • GERN N/A
  • Industry
  • UVSP Major Banks
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • UVSP Finance
  • GERN Health Care
  • Exchange
  • UVSP Nasdaq
  • GERN Nasdaq
  • Market Cap
  • UVSP 865.0M
  • GERN 823.0M
  • IPO Year
  • UVSP 1989
  • GERN 1996
  • Fundamental
  • Price
  • UVSP $30.76
  • GERN $1.27
  • Analyst Decision
  • UVSP Hold
  • GERN Buy
  • Analyst Count
  • UVSP 2
  • GERN 8
  • Target Price
  • UVSP $29.00
  • GERN $3.71
  • AVG Volume (30 Days)
  • UVSP 104.3K
  • GERN 6.4M
  • Earning Date
  • UVSP 10-22-2025
  • GERN 11-06-2025
  • Dividend Yield
  • UVSP 2.86%
  • GERN N/A
  • EPS Growth
  • UVSP 12.33
  • GERN N/A
  • EPS
  • UVSP 2.73
  • GERN N/A
  • Revenue
  • UVSP $298,354,000.00
  • GERN $164,447,000.00
  • Revenue This Year
  • UVSP $12.42
  • GERN $175.15
  • Revenue Next Year
  • UVSP $4.67
  • GERN $56.61
  • P/E Ratio
  • UVSP $11.27
  • GERN N/A
  • Revenue Growth
  • UVSP 4.09
  • GERN 11877.20
  • 52 Week Low
  • UVSP $22.83
  • GERN $1.09
  • 52 Week High
  • UVSP $32.86
  • GERN $4.83
  • Technical
  • Relative Strength Index (RSI)
  • UVSP 48.86
  • GERN 40.76
  • Support Level
  • UVSP $30.82
  • GERN $1.27
  • Resistance Level
  • UVSP $31.43
  • GERN $1.52
  • Average True Range (ATR)
  • UVSP 0.68
  • GERN 0.06
  • MACD
  • UVSP -0.08
  • GERN -0.02
  • Stochastic Oscillator
  • UVSP 37.00
  • GERN 0.00

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: